Michael D. Rosenblum

Michael D. Rosenblum

Auto-generated profile, based on publicly available information

Michael D. Rosenblum

Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Cell
Verified
Journal Article
Closed access
NANiwa Ali
Niwa Ali
BZBahar Zirak
Bahar Zirak
RRRobert Sanchez Rodriguez
Robert Sanchez Rodriguez
MPMariela L. Pauli
Mariela L. Pauli
HTHong-An Truong
Hong-An Truong
MRMichael D. Rosenblum
Michael D. Rosenblum

1 November 2015 in Immunity
Verified
Journal Article
Closed access
TSTiffany C. Scharschmidt
Tiffany C. Scharschmidt
KVKimberly S. Vasquez
Kimberly S. Vasquez
HTHong-An Truong
Hong-An Truong
SGSofia V. Gearty
Sofia V. Gearty
MPMariela L. Pauli
Mariela L. Pauli
MRMichael D. Rosenblum
Michael D. Rosenblum

1 March 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ANAudrey Nosbaum
Audrey Nosbaum
NPNicolas Prevel
Nicolas Prevel
HTHong-An Truong
Hong-An Truong
PMPooja Mehta
Pooja Mehta
MEMonika Ettinger
Monika Ettinger
MRMichael D. Rosenblum
Michael D. Rosenblum
Foxp3-expressing regulatory T cells (Tregs) reside in tissues where they control inflammation and mediate tissue-specific functions. The skin of mice and humans contain a large number of Tregs; however, the mechanisms of how these cells function in skin remain largely unknown. In this article, we show that Tregs facilitate cutaneous wound healing. Highly activated Tregs accumulated in skin early after wounding, and specific ablation of these cells resulted in delayed wound re-epithelialization and kinetics of wound closure. Tregs in wounded skin attenuated IFN-γ production and proinflammatory macrophage accumulation. Upon wounding, Tregs induce expression of the epidermal growth factor receptor (EGFR). Lineage-specific deletion of EGFR in Tregs resulted in reduced Treg accumulation and activation in wounded skin, delayed wound closure, and increased proinflammatory macrophage accumulation. Taken together, our results reveal a novel role for Tregs in facilitating skin wound repair and suggest that they use the EGFR pathway to mediate these effects.

5 July 2019 in Science Immunology
Verified
Journal Article
Closed access
PDF file
MKMaria M. Klicznik
Maria M. Klicznik
PMPeter A. Morawski
Peter A. Morawski
BHBarbara Höllbacher
Barbara Höllbacher
SVSuraj R. Varkhande
Suraj R. Varkhande
SMSamantha J. Motley
Samantha J. Motley
IGIris K. Gratz
Iris K. Gratz
Human blood and lymph contain circulating CD4 + CD103 + cutaneous resident memory T cells that can seed distant skin sites. See the related Focus by Carbone and Gebhardt .

25 March 2022 in Science Immunology
Verified
Journal Article
Closed access
JMJoshua M. Moreau
Joshua M. Moreau
MVMaria Velegraki
Maria Velegraki
CBChelsea Bolyard
Chelsea Bolyard
MRMichael D. Rosenblum
Michael D. Rosenblum
ZLZihai Li
Zihai Li
Transforming growth factor–β1 (TGF-β1) is inextricably linked to regulatory T cell (T reg ) biology. However, precisely untangling the role for TGF-β1 in T reg differentiation and function is complicated by the pleiotropic and context-dependent activity of this cytokine and the multifaceted biology of T regs . Among CD4 + T cells, T regs are the major producers of latent TGF-β1 and are uniquely able to activate this cytokine via expression of cell surface docking receptor glycoprotein A repetitions predominant (GARP) and αv integrins. Although a preponderance of evidence indicates no essential roles for T reg -derived TGF-β1 in T reg immunosuppression, TGF-β1 signaling is crucial for T reg development in the thymus and periphery. Furthermore, active TGF-β1 instructs the differentiation of other T cell subsets, including T H 17 cells. Here, we will review TGF-β1 signaling in T reg development and function and discuss knowledge gaps, future research, and the TGF-β1/T reg axis in the context of cancer immunotherapy and fibrosis.

1 April 2017 in Cell Host & Microbe
Verified
Journal Article
Closed access
TSTiffany C. Scharschmidt
Tiffany C. Scharschmidt
KVKimberly S. Vasquez
Kimberly S. Vasquez
MPMariela L. Pauli
Mariela L. Pauli
ELElizabeth G. Leitner
Elizabeth G. Leitner
KCKevin Chu
Kevin Chu
MRMichael D. Rosenblum
Michael D. Rosenblum